CommercialCoverageMedium impact
07.05.06h, Transcatheter Arterial Chemoembolization (TACE) of Hepatic Malignancies
Independence Blue Cross·Radiology, Oncology, Gastroenterology +1 more·Medical Policy
Effective date
Mar 5, 2025
We identified it
Jun 19, 2026
Summary
The TACE (Transcatheter Arterial Chemoembolization) policy for hepatic malignancies has been reissued with an effective date of March 5, 2025. This is a policy reissue rather than new content, suggesting potential clarifications or administrative updates to existing coverage criteria.
Action Required
By March 5, 2025: Review updated TACE policy requirements for hepatic malignancy cases. Billing team should verify current coverage criteria and documentation requirements remain aligned with practice protocols. Interventional radiology and oncology teams should confirm any changes to medical necessity criteria.